The pharmacologic treatment of schizophrenia remains a critical component in the short-and
long-term management of this disease. Considerable progress has been made in …

Objective: To review the historical development of the psychopharmacological treatment of
schizophrenia. Method: A chronological literature review of the clinical practices and …

The primary objectives in the treatment of schizophrenia are to reduce the frequency and
severity of psychotic exacerbation, ameliorate a broad range of symptoms, and improve …

Originally published in February 2004. This guideline is more than 5 years old and has not
yet been updated to ensure that it reflects current knowledge and practice. In accordance …

The introduction of second-generation antipsychotics and cognitive therapies for
schizophrenia over the past two decades generated considerable optimism about …

Despite growing awareness in the psychiatric community of the multifaceted medical needs
of the severely mentally ill, statistics show that as much as 60% of all schizophrenia patients …

INTRODUCTION—Depressive symptoms are frequent clinical features in patients with
schizophrenia. Depression is associated with a less favorable patient course and poorer …

Therapeutic advances over the last four decades have enabled most persons with
schizophrenia to live in the community. Nevertheless, the majority will continue to …

Deals with the subject of Schizophrenia and Other Psychotic Disorders. With more than 600
entries, this work features a foreword and an introduction, and references and appendixes …